CIK 0001356090 · Non-accelerated filer<br>Smaller reporting company
PRECIGEN, INC.
Sign in to watch- Ticker
- PGEN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- Phone
- 301-556-9900
- Business address
- 20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD, 20876
- Former names
- INTREXON CORP
- Open-market buys, last 90 days
- $24,662
- in 1 filing
- Open-market sales, last 90 days
- $2,345,145
- in 3 filings, $969K under 10b5-1 plans
Net −$2,320,483. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-29 | Thomasian Harry Jr. Chief Financial Officer | Sale 10b5-1 | −28,571 | $5.78 | $165K | 525,964 |
| 2026-06-29 | Shah Rutul R Chief Operating Officer | Option exercise 10b5-1 | +42,924 | $2.33 | $100K | 540,675 |
| 2026-06-29 | Shah Rutul R Chief Operating Officer | Sale 10b5-1 | −42,924 | $5.85 | $251K | 497,751 |
| 2026-06-29 | Shah Rutul R Chief Operating Officer | Option exercise · Option to Purchase Common Stock (Right to Buy) 10b5-1 | −42,924 | 157,076 | ||
| 2026-06-29 | Sabzevari Helen President and CEO | Option exercise 10b5-1 | +346,836 | $2.33 | $808K | 4,115,708 |
| 2026-06-29 | Sabzevari Helen President and CEO | Sale 10b5-1 | −346,836 | $5.89 | $2.0M | 3,768,872 |
| 2026-06-29 | Sabzevari Helen President and CEO | Option exercise · Option to Purchase Common Stock (Right to Buy) 10b5-1 | −346,836 | 500,164 | ||
| 2026-05-28 | Thomasian Harry Jr. Chief Financial Officer | Sale | −41,884 | $4.36 | $183K | 554,535 |
| 2026-05-28 | Tennant Phil Chief Commercial Officer | Sale | −30,272 | $4.36 | $132K | 139,369 |
| 2026-05-28 | Shah Rutul R Chief Operating Officer | Sale | −42,703 | $4.36 | $186K | 497,751 |
| 2026-05-28 | Lehr Donald P. Chief Legal Officer | Sale | −29,131 | $4.36 | $127K | 755,461 |
| 2026-05-28 | Sabzevari Helen President and CEO | Sale | −119,250 | $4.36 | $520K | 3,768,872 |
| 2026-05-23 | Thomasian Harry Jr. Chief Financial Officer | Option exercise | +87,500 | 596,419 | ||
| 2026-05-23 | Thomasian Harry Jr. Chief Financial Officer | Option exercise · Restricted Stock Units | −87,500 | 87,500 | ||
| 2026-05-23 | Tennant Phil Chief Commercial Officer | Option exercise | +62,500 | 169,641 | ||
| 2026-05-23 | Tennant Phil Chief Commercial Officer | Option exercise · Restricted Stock Units | −62,500 | 62,500 | ||
| 2026-05-23 | Shah Rutul R Chief Operating Officer | Option exercise | +90,000 | 540,454 | ||
| 2026-05-23 | Shah Rutul R Chief Operating Officer | Option exercise · Restricted Stock Units | −90,000 | 90,000 | ||
| 2026-05-23 | Sabzevari Helen President and CEO | Option exercise | +250,000 | 3,888,122 | ||
| 2026-05-23 | Sabzevari Helen President and CEO | Option exercise · Restricted Stock Units | −250,000 | 250,000 |
Page 3 of 26 · 502 trades